Highland Capital Management (Tennessee)’s Roivant Sciences ROIV Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$472K	Buy	+13,336	New	+$394K	0.02%	320

Other funds holding ROIV

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PDM

Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Cache Advisors San Francisco, California $1.18B AUM 44.04% 1-Year Est. Return

Highland Capital Management (Tennessee)'s ROIV Position: Q2 2026 in Review

Highland Capital Management (Tennessee) opened a new position in Roivant Sciences (ROIV) in Q2 2026: 13,336 shares worth $472K. The stake represents 0.02% of the portfolio and ranks #320 among its holdings.

178 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Highland Capital Management (Tennessee) held 13,336 shares of Roivant Sciences worth $472K as of Q2 2026.
Roivant Sciences was a new Highland Capital Management (Tennessee) position in Q2 2026.
Roivant Sciences made up 0.02% of Highland Capital Management (Tennessee)'s portfolio in Q2 2026, its #320 holding.
178 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2026, filed 21 Jul 2026.